Has Bled Score Calculator
Calculate HAS-BLED bleeding risk score for patients on anticoagulation. Assess major bleeding risk in atrial fibrillation.
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
HAS-BLED = H(1) + A(renal 1, liver 1) + S(1) + B(1) + L(1) + E(1) + D(drugs 1, alcohol 1)
Each criterion adds 1 point. Abnormal renal and liver function score independently (max 2 for A). Drugs and alcohol score independently (max 2 for D). Total ranges from 0 to 9. Score ≥3 indicates high bleeding risk requiring close monitoring.
Worked Examples
Example 1: Low Bleeding Risk
Problem:55-year-old male with controlled hypertension on warfarin, stable INR.
Solution:Hypertension: +1 All others: 0 Total HAS-BLED = 1 Bleeding risk: 1.02%/year Category: Low risk
Result:HAS-BLED 1 — Low Risk, safe for anticoagulation
Example 2: High Bleeding Risk
Problem:72-year-old female with liver disease, labile INR, on aspirin and warfarin, drinks alcohol regularly.
Solution:Liver function: +1 Labile INR: +1 Elderly: +1 Drugs: +1 Alcohol: +1 Total HAS-BLED = 5 Bleeding risk: 12.5%/year Category: Very High risk
Result:HAS-BLED 5 — Very High Risk, address modifiable factors
Frequently Asked Questions
What is the HAS-BLED score?
HAS-BLED is a scoring system to assess the 1-year risk of major bleeding in patients on anticoagulation for atrial fibrillation. The acronym stands for: Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile INR, Elderly, and Drugs/alcohol. Scores range from 0 to 9, with scores ≥3 indicating high bleeding risk requiring caution and regular review.
Does a high HAS-BLED score mean I should stop anticoagulation?
No. A high HAS-BLED score does not mean anticoagulation should be withheld. Instead, it highlights patients who need more careful monitoring and attention to modifiable risk factors. Many risk factors for bleeding are also risk factors for stroke, so stopping anticoagulation may increase net clinical harm. The score should prompt review of modifiable factors like blood pressure control, medication interactions, and alcohol use.
What are the modifiable risk factors in HAS-BLED?
Modifiable risk factors include: Hypertension (improve BP control), Labile INR (improve time in therapeutic range or switch to DOAC), Drugs (discontinue unnecessary antiplatelet agents or NSAIDs), and Alcohol (reduce consumption). Addressing these factors can lower bleeding risk while maintaining the benefits of anticoagulation.
How does HAS-BLED compare to other bleeding risk scores?
HAS-BLED has been validated in multiple large cohorts and is recommended by ESC guidelines. It outperforms older scores like HEMORR2HAGES and ATRIA in predicting major bleeding. Its simplicity and clinical applicability make it the most widely used bleeding risk assessment tool in atrial fibrillation management.
How do HAS-BLED and CHA2DS2-VASc work together in atrial fibrillation?
CHA2DS2-VASc estimates ischaemic stroke risk and answers whether oral anticoagulation is indicated; HAS-BLED estimates major bleeding risk on that therapy and answers how intensively the patient should be monitored. They deliberately share format but not purpose. Because both include age, hypertension and prior stroke, the two scores usually rise together, so a high bleeding score rarely identifies a patient who would be safer untreated — it identifies one who needs correction of modifiable factors and closer review.
Why do abnormal renal and abnormal liver function score separately?
The letter A in HAS-BLED covers two independent organ-dysfunction criteria, each worth one point, so a patient with both scores 2 for that letter alone. Renal impairment raises bleeding risk partly through reduced clearance of renally excreted anticoagulants and uraemic platelet dysfunction; hepatic impairment does so through reduced synthesis of clotting factors and thrombocytopenia of portal hypertension. Scoring them separately is also why the maximum total is 9 rather than 7.
What does labile INR mean and does it apply to patients on a DOAC?
Labile INR describes unstable or excessively high international normalised ratios, conventionally captured as a time in therapeutic range below 60% for a patient on a vitamin K antagonist such as warfarin. It is not applicable to direct oral anticoagulants, which are not INR-monitored, so that criterion is generally scored as absent for DOAC patients. A persistently poor time in therapeutic range is itself a recognised prompt to review the choice of anticoagulant with the prescribing clinician.
What counts as a major bleed in the outcome HAS-BLED predicts?
The score was derived against major bleeding events, conventionally defined as bleeding requiring hospital admission, causing a fall in haemoglobin, requiring transfusion, or occurring at a critical site such as intracranial. Nuisance bleeding — bruising, minor epistaxis, gum bleeding — is far more common and is not what the score estimates. Understanding this distinction matters when discussing risk with a patient, because the bleeding they notice most is not the bleeding being predicted.
When should the HAS-BLED score be recalculated?
It is not a one-off number. Several components change over time: blood pressure control can improve, an NSAID or antiplatelet agent can be stopped, alcohol intake can fall, time in therapeutic range can improve, and renal function or age can move a patient into a scoring category. Guidelines favour reassessing bleeding risk at routine anticoagulation reviews so that correctable contributors are picked up rather than assumed fixed at the original assessment.
Why is a bleeding risk score not used as a threshold to withhold anticoagulation?
Because it estimates only one side of the trade-off. Withholding anticoagulation removes the bleeding hazard but restores the untreated stroke risk, which in atrial fibrillation is often the larger harm, and the shared risk factors mean the highest-bleeding-risk patients are frequently the highest-stroke-risk patients too. The score is designed to flag patients for factor modification and closer follow-up. Any decision about starting, changing or stopping anticoagulation belongs with the treating clinician.
References
- Pisters R et al. — A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding (Chest, 2010)
- 2020 ESC Guidelines for the management of atrial fibrillation
- Lip GYH et al. — Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated atrial fibrillation patients: the HAS-BLED score (J Am Coll Cardiol, 2011)
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮CHADS2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
🧮Cha2ds2-VASc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
🧮HEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
🧮TIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.
🧮Wells Score DVT Calculator
Estimate pre-test probability of deep vein thrombosis using the Wells clinical criteria.
🧮Wells Score PE Calculator
Estimate pre-test probability of pulmonary embolism using the Wells criteria.
🧮Framingham Risk Score Calculator
Calculate 10-year cardiovascular disease risk using the Framingham risk assessment model.
🧮APACHE II Score Calculator
Calculate the APACHE II severity of disease score for ICU patients.